Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital
Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions
Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital
Cartier Cuts 7.9 g/t Au Over 4.0 m Within A Broader Segment of 2.3 g/t Au Over 19.0 m at Hope Sector ; Unlocks New High-Grade Gold Zone in Underexplored Pontiac Sediments
CHARBONE annonce la signature d'un contrat d'approvisionnement de trois ans en oxygene UHP avec un client strategique americain, renforcant sa presence aux Etats-Unis
CHARBONE Announces the Signing of a Three-year UHP Oxygen Supply Contract with a Strategic American Customer, Strengthening its Presence in the United States
